Immuron Limited (IMRN) - News Archive

Building Bridges: Immuron Partners with InvestorHub to Revolutionize Investor Engagement Melbourne, Australia - August 26, 2025 In a strategic move poised to redefine investor relations, Immuron Limited, the biopharmace...

In a strategic move to enhance its offerings in the digestive health sector, Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian-based biopharmaceutical company, has announced an exclusive distribution agreement wit...

Immuron Limited Reports Sustained Sales Momentum for Travelan amidst Financial Challenges MELBOURNE, Australia, Oct. 15, 2024 Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian-based and globally integrated biophar...

In recent developments that underscore the intersection of innovation and global health challenges, Immuron Limited, an Australian biopharmaceutical company, has announced positive interim results following their collab...

Immuron Requests Pre-IND Meeting with FDA for IMM-529 and Shares Soar 17.82% in Five Trading DaysMelbourne, Australia - Immuron Limited (ASX: IMC; NASDAQ: IMRN), a leading global biopharmaceutical company based in Austr...